Steppin' Up: Positive Youth Development Program
Public ClinicalTrials.gov record NCT00341224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
As an antidote to juvenile aggression and violence, which has increased in recent years, group mentoring offers a viable alternative to intensive one-on-one mentoring. However, no group-mentoring programs have been evaluated. The purpose of this study is to assess the efficacy of a school-based, group-mentoring intervention designed to prevent aggressive and deviant behavior among early adolescents. Study participants will be incoming 6th grade students from two inner-city Baltimore middle schools and their parents. Approximately 1,400 students and their parents are expected to participate. All 6th grade students in these schools are eligible for the study. Weekly student group-mentoring sessions are the principal component of this study. These groups will be held during the school day and will be designed to increase social skills and encourage academic engagement, restraint, and problem-solving. A master's level professional will direct and conduct these intervention activities, which will employ the use of field trips, cooperative games, discussion of real-life situations, and role playing. Students will also complete a 1-hour written survey each fall and spring from grades 6-8 about the program and about attitudes and behaviors related to school involvement and staying healthy and safe. Study staff will contact participants' teachers and review their past and current school records, including attendance, grades, and disciplinary information. Parents may be asked to participate in group meetings and will complete in-person or telephone interviews (about 20 minutes each) about similar information over a 3-year period (6th grade to 8th grade).
Study identification
- NCT ID
- NCT00341224
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2003
- Primary completion
- Dec 8, 2009
- Completion
- Dec 8, 2009
- Last update posted
- Jul 1, 2017
2003 – 2009
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institute of Child Health and Human Development (NICHD), 9000 Rockville | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00341224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2017 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00341224 live on ClinicalTrials.gov.